Ami Organics Ltd IPO

Last Updated: 03 January 2022 8:08 AM by 5Paisa

The offer comprises a fresh issue and an offer for sale. The fresh issue is of ₹200cr after the company chose the pre-IPO placement of ₹100 cr. Out of the proceeds from the IPO and pre-IPO placement, ₹140 cr would be utilized towards repayment/prepayment of certain loans availed by the company while ₹90cr would be used for funding the working capital requirements of the company and the balance of the fresh issue would be used for general corporate purposes. The offer for sale is 6,059,600 shares amounting to ₹369.6cr, the proceeds of which would go directly to the selling shareholders.

Ami Organics Shareholding

Ami Organics Limited is a research and development (‘R&D’) driven manufacturer of specialty chemicals with varied end usage, focusing on the development and manufacturing of advanced pharmaceutical intermediates (‘Pharma Intermediates’) for regulated and generic active pharmaceutical ingredients (‘APIs’) and New Chemical Entities (‘NCE’) and key starting material for agrochemical and fine chemicals, especially from their recent acquisition of the business of Gujarat Organics Limited (‘GOL’). The Pharma Intermediates which we manufacture, find application in certain high-growth therapeutic areas including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant, commanding significant market share both in India and globally.

Ami Organics - Financials